Evaluation of A plasma for incompatible patients.

Gregory M OlsenMichael PasswaterMonique HugginsFaisal MukhtarPeter Pelletier

Published in: Transfusion (2020)

No evidence of ABO immune-mediated hemolysis was observed in the patient population. The results of the study support the safety of A plasma transfusion in B and AB patients. We hypothesize the relationship observed between A plasma volume and mortality/ICU stay may be from collinearity with disease severity.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
cardiac surgery
acute kidney injury
patient reported outcomes
risk factors